Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Congress Considers Legislation to Secure Drug Supply Chain

Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.
Jun 2, 2013

Bills to regulate drug compounding and establish a national track and trace system face political and policy differences.

Regulatory Roundup

An overview of the latest regulatory developments for malaria drugs, biosimilars, and global standards.
Jun 2, 2013

An overview of the latest regulatory developments for malaria drugs, biosimilars, and global standards.

Regulatory Convergence Sought for Global Pharma Market

Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.
May 2, 2013

Manufacturers work with international authorities to harmonize drug registration and supply-chain oversight.

Regulatory Roundup

May 2, 2013

FDA faces budget crunch; Supreme Court hears key cases

Regulatory Roundup

Latest news about compound pharmacies, biosimilars, prescription drug purchases, and other regulatory topics.
Apr 2, 2013

Latest news about compound pharmacies, biosimilars, prescription drug purchases, and other regulatory topics.

Manufacturers Under Pressure to Manage Painkillers

Opioid abuse generates calls for efforts to curb distribution, develop abuse-resistant formulations.
Apr 2, 2013

Opioid abuse generates calls for efforts to curb distribution, develop abuse-resistant formulations.

Vaccine Innovation Yields New Products and Processes

Vaccine development is benefiting from manufacturing advances and support for global health.
Mar 2, 2013

Vaccine development is benefiting from manufacturing advances and support for global health.

GMP Compliance Becomes Prominent Enforcement Issue

Prosecutors and regulators challenge manufacturing quality failings likely to cause patient harm.
Feb 2, 2013

Prosecutors and regulators challenge manufacturing quality failings likely to cause patient harm.

Drug Quality at Center Stage for FDA and Manufacturers

Shortages and compounding disaster spur efforts to overhaul manufacturing oversight and stimulate industry improvements.
Jan 1, 2013

Shortages and compounding disaster spur efforts to overhaul manufacturing oversight and stimulate industry improvements.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here